UCL denames buildings named after eugenicists
By University College London,
UCL News
| 06. 19. 2020
The decision was made by UCL’s President & Provost Professor Michael Arthur and ratified by Council - the university’s governing body - following a recommendation from UCL’s Buildings Naming and Renaming Committee.
Signs on the Galton Lecture Theatre, Pearson Building and Pearson Lecture Theatre will be taken down with immediate effect. Other changes to the names on maps and signposts around the UCL estate will take place as soon as is practicable.
Victorian scientist Francis Galton coined the term eugenics and endowed UCL with his personal collection and archive along with a bequest for the country’s first professorial Chair of Eugenics. Karl Pearson was the first holder of this chair.
The move is one step in a range of actions aimed at acknowledging and addressing the university’s historical links with the eugenics movement. It follows a series of recommendations made by members of the Inquiry into the History of Eugenics at UCL, which reported earlier this year.
A Response Group of senior UCL representatives – including academic staff, equality experts and the Students’ Union – is being formed to consider...
Related Articles
By Harry Hunter, PET BioNews | 08.11.2025
The Parliamentary Office of Science and Technology has announced plans to publish a POSTnote and called for submissions on surrogacy law in the UK and internationally.
The current UK surrogacy laws, largely based on legislation from the 1980s, have been...
By Sayantani DasGupta, MedPage Today | 08.05.2025
It's just a jeans ad.
It's not that deep.
It's just social media outrage.
Should physicians care about the recent American Eagle "Sydney Sweeney Has Good Genes Jeans" controversy? What, if anything, does the provocative campaign have to...
By Zusha Elinson, The Wall Street Journal | 08.12.2025
BERKELEY, Calif.—Tsvi Benson-Tilsen, a mathematician, spent seven years researching how to keep an advanced form of artificial intelligence from destroying humanity before he concluded that stopping it wasn’t possible—at least anytime soon.
Now, he’s turned his considerable brainpower to promoting...
By Gregory Laub and Hannah Glaser, MedPage Today | 08.07.2025
In this MedPage Today interview, Leigh Turner, PhD, a professor of health policy and bioethics at the University of California Irvine, unpacks the growing influence of stem cell clinics and the blurred line between medicine and marketing. He explains how...